Furthermore, incorporating these driving factors, especially potassium lactate in non-NO-producing tumor cells to reduce tumor growth, was paramount in showing the importance of reprogrammed glycolytic metabolism in IFN-γ-signaling. The gene discussed is IFNG; the disease is neoplasm.